TABLE 2.
Association of ELK1 expression with clinicopathological variables in pancreatic ductal adenocarcinoma.
| Clinicopathological characteristic | n (%) | Elk1 staining (n; %) | p-value | |
|---|---|---|---|---|
| Low | High | |||
| Age (year) | 0.137 | |||
| <60 | 86 (48.86) | 44 (51.16) | 42 (48.84) | |
| ≥60 | 90 (51.14) | 56 (62.22) | 34 (37.78) | |
| Sex | 0.173 | |||
| Male | 108 (61.36) | 57 (52.78) | 51 (47.22) | |
| Female | 68 (38.64) | 43 (63.23) | 25 (36.76) | |
| Clinical stages | *0.005 | |||
| I/II | 138 (78.41) | 86 (62.32) | 52 (39.86) | |
| III/IV | 38 (21.59) | 14 (36.84) | 24 (63.16) | |
| Tumor location | 0.142 | |||
| Head | 112 (63.64) | 59 (50.89) | 53 (49.11) | |
| Body/tail | 64 (36.36) | 41 (60.93) | 23 (39.07) | |
| Tumor size | 0.102 | |||
| ≤4 cm | 58 (32.95) | 38 (62.07) | 20 (37.93) | |
| >4 cm | 118 (67.05) | 62 (50.85) | 56 (49.15) | |
| Differentiation | *0.041 | |||
| Weak to moderately | 110 (62.50) | 69 (62.73) | 41 (37.27) | |
| Poorly | 66 (37.50) | 31 (46.97) | 35 (53.03) | |
| N infiltration | 0.271 | |||
| Positive | 165 (93.75) | 92 (55.76) | 73 (44.24) | |
| Negative | 11 (6.25) | 8 (72.73) | 3 (27.27) | |
| Lymphnode infiltration | *0.050 | |||
| Positive | 128 (72.73) | 67 (52.34) | 61 (47.66) | |
| Negative | 48 (27.27) | 33 (68.75) | 15 (31.25) | |